The Different Design of Orthokeratology

July 14, 2023 updated by: Tianjin Eye Hospital

The Effectiveness and Safety of Different Design of Orthokeratology Lenses to Reduce Myopia Growth

In this study, we intend to enroll orthokeratology subjects aged 8-18 years old with binocular myopia up to and including -4.00 D. They were randomly selected to wear both orthokeratology of different designs, one with an aspheric wide inversion zone design in the optical zone and the other with a traditional spherical curved segment design, and to investigate the differences between these two lenses in terms of their effectiveness in myopia retardation, defocus, and aberration.

Study Overview

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tianjin, China, 300020
        • Tianjin Eye Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The age is greater than 8 years and less than 18 years
  • The myopia was within -4.00D (including -4.00D), and the astigmatism was within 1.50D (including 1.50D) in both eyes.
  • Be able to complete 12 months of follow-up
  • They were able to understand the purpose of the trial, volunteered to participate, and signed informed consent by the subjects themselves or their legal guardians

Exclusion Criteria:

  • One eye met the inclusion criteria
  • Patients with systemic diseases causing immunocompromised or affecting orthokeratology
  • There are other eye diseases that affect orthokeratology lens wearing, such as dacryocystitis, blepharitis, various inflammation, glaucoma, etc
  • Abnormal cornea
  • Previous corneal surgery or corneal trauma history
  • Active keratitis (e.g., corneal infection)
  • Patients with best corrected distance visual acuity of less than 5.0
  • Patients with corneal flat curvature lower than 39.00D, or higher than 48.00D
  • Patients with refractive instability
  • Patients with overt strabismus
  • The corneal epithelium showed obvious fluorescent staining, which was not suitable for patients wearing orthokeratology lenses
  • Patients with dry eye are not suitable for orthokeratology
  • Patients with corneal endothelial cell density less than 2000 cells /mm2
  • Patients who had worn rigid contact lenses (including orthokeratology lenses) within the previous 30 days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
An orthokeratology lens with an altered optical zone design is designed for an aspherical wide inversion arc in the optical zone
Active Comparator: Control group
Subjects wore the orthokeratology with traditional spherical design in the optical zone
No Intervention: Blank control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in axial length
Time Frame: The change of baseline and 1years
Axial length was measured with a biometer
The change of baseline and 1years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2020

Primary Completion (Actual)

June 1, 2023

Study Completion (Actual)

June 1, 2023

Study Registration Dates

First Submitted

July 14, 2023

First Submitted That Met QC Criteria

July 14, 2023

First Posted (Actual)

July 21, 2023

Study Record Updates

Last Update Posted (Actual)

July 21, 2023

Last Update Submitted That Met QC Criteria

July 14, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KY2023031

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

3
Subscribe